Special Issue "Do Nanocarriers Enhance Targeted Drug Delivery Mechanisms?"

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".

Deadline for manuscript submissions: 22 August 2024 | Viewed by 182

Special Issue Editors

Prof. Dr. Chau-Zen Wang
E-Mail Website
Guest Editor
Department of Physiology, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
Interests: regeneration medicine; discoidin domain receptor (DDR) function-transgenic mice; physiology; nanomedicine
Orthopedic Research Center, School of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
Interests: cancer biology; regenerative medicine; nano-medicine; drug delivery
Special Issues, Collections and Topics in MDPI journals
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Interests: cancer chemoprevention; nanomedicine; natural products; histamine h3R antagonists

Special Issue Information

Dear Colleagues,

Over the last few years, significant progress has been made in drug delivery systems to facilitate the targeted distribution of naturally derived active components, chemically derived therapeutic agents, and chemotherapeutic drugs to treat many degenerative diseases, including cancer and diabetes mellitus. Several delivery methods have been effectively utilized for targeted drug delivery mechanisms. However, many challenges must be addressed before use in clinical applications. Advanced technology must be developed to successfully deliver drugs to their target sites. Therefore, ongoing research on nano-based drug delivery systems aims to enhance the efficiency and effectiveness of drug delivery mechanisms.

Within the theme “Do Nanocarriers Enhance Targeted Drug Delivery Mechanisms?", we invite your contributions across a spectrum of topics:

  • Novel nanocarrier designs and their applications.
  • Polymer- and lipid-based nanocarriers.
  • Monoclonal antibodies in targeted drug delivery.
  • Exosome-based drug delivery.
  • Disease-targeted drug delivery mechanisms.
  • Preclinical and clinical applications of targeted drug delivery.
  • Biomedical applications of nanocarriers.
  • Diagnostics uses of nanocarriers.

We aim to provide a comprehensive platform for researchers to share their expertise and contribute to advancing nanocarrier-assisted drug delivery systems. By shedding light on recent developments, we can collectively shape the future of targeted therapeutics.

Prof. Dr. Chau-Zen Wang
Dr. Mariadoss Arokia Vijaya Anand
Dr. Karthikkumar Venkatachalam
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • regenerative diseases
  • nanobiopharmaceuticals
  • nanocarrier
  • targeted drug delivery

Published Papers

This special issue is now open for submission.
Back to TopTop